A nurse is performing medication reconciliation for a client newly admitted. Which of the following actions should the nurse take?

Choice A reason: Hypothyroidism requires lifelong levothyroxine because the thyroid gland doesn’t regain function in most cases, such as Hashimoto’s disease. Stating several months misleads the client, implying a temporary treatment, which is inaccurate. This chronic condition demands continuous hormone replacement to maintain metabolism, energy, and organ function. Temporary therapy applies to transient conditions, not primary hypothyroidism, so this statement fails to reflect the long-term nature of management needed.

Choice B reason: Hypothyroidism slows metabolism due to low thyroid hormone levels, reducing basal metabolic rate and calorie burning. This leads to weight gain as energy expenditure drops, even with unchanged diet, a common symptom. Educating clients about this helps them understand and manage expectations, linking it to the condition’s physiology. It’s a key teaching point, as weight gain often prompts diagnosis and motivates adherence to levothyroxine therapy.

Choice C reason: Laboratory tests like TSH and free T4 are essential to monitor levothyroxine’s effectiveness in hypothyroidism, ensuring the dose restores euthyroid status. These tests, typically done every 6-12 weeks initially then annually, guide adjustments to prevent under- or over-treatment. Including this in teaching empowers clients to participate in their care, understanding why follow-ups matter. It reflects standard practice for managing this endocrine disorder accurately.

Choice D reason: Increased perspiration is a hyperthyroidism symptom, where excess thyroid hormone accelerates metabolism, raising body heat. Hypothyroidism, conversely, causes cold intolerance and dry skin due to slowed metabolism, reducing sweat production. This statement contradicts hypothyroidism’s physiology, misinforming the client about expected symptoms. Correct teaching would highlight cold sensitivity instead, aligning with the condition’s impact on thermoregulation and skin.

Choice E reason: Hypothyroidism slows gastrointestinal motility due to decreased thyroid hormone, often causing constipation as a complication. A high-fiber diet increases bulk and promotes bowel movements, preventing this issue. Teaching this dietary adjustment addresses a common, manageable symptom, improving quality of life. It’s a scientifically supported recommendation, as fiber counteracts the sluggish digestion typical in hypothyroid states, making it vital education.

Choice A reason: Omega-3 fish oil, rich in EPA and DHA, lowers triglycerides by reducing hepatic VLDL production and enhances LDL clearance, cutting cholesterol levels. Clinical studies show it decreases cardiovascular risk in hyperlipidemia. For a client with high cholesterol, this supplement directly targets lipid metabolism, offering a therapeutic benefit, making it the appropriate choice here.

Choice B reason: Glucosamine, derived from shellfish, supports cartilage repair in osteoarthritis by aiding glycosaminoglycan synthesis, not affecting cholesterol pathways. It lacks lipid-lowering properties, focusing on joint health instead. For a client with high cholesterol, this supplement offers no benefit to lipid profiles, rendering it irrelevant to the goal of reducing levels.

Choice C reason: Cranberry tablets inhibit bacterial adhesion in the urinary tract, preventing infections, but have no impact on cholesterol metabolism or lipid levels. Their anthocyanins benefit bladder health, not cardiovascular risk factors. In high cholesterol, this supplement doesn’t address the condition, making it an ineffective choice for this client’s needs.

Choice D reason: Ginkgo biloba enhances cerebral blood flow via vasodilation, potentially aiding memory, but it doesn’t alter cholesterol synthesis or clearance. Its antioxidants target circulation, not lipids directly. For a client with high cholesterol, this supplement lacks evidence of lowering levels, failing to meet the therapeutic aim here.